GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.0653 $0.257 Friday, 19th Apr 2024 JAGX stock ended at $0.157. This is 11.41% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 12.25% from a day low at $0.154 to a day high of $0.172.
90 days $0.0519 $0.257
52 weeks $0.0519 $1.22

Historical Jaguar Health, Inc. prices

Date Open High Low Close Volume
2024-04-19 $0.162 $0.172 $0.154 $0.157 30 051 009
2024-04-18 $0.144 $0.185 $0.142 $0.177 68 325 514
2024-04-17 $0.185 $0.208 $0.150 $0.165 131 679 804
2024-04-16 $0.104 $0.257 $0.104 $0.178 598 061 500
2024-04-15 $0.102 $0.138 $0.100 $0.119 113 572 916
2024-04-12 $0.109 $0.109 $0.0902 $0.0903 26 012 895
2024-04-11 $0.111 $0.118 $0.101 $0.108 27 988 567
2024-04-10 $0.125 $0.133 $0.101 $0.116 171 399 038
2024-04-09 $0.0803 $0.0958 $0.0801 $0.0900 39 056 844
2024-04-08 $0.0900 $0.0910 $0.0788 $0.0820 36 139 168
2024-04-05 $0.0800 $0.0884 $0.0780 $0.0840 22 684 976
2024-04-04 $0.0790 $0.0849 $0.0750 $0.0774 32 232 593
2024-04-03 $0.0740 $0.0789 $0.0719 $0.0741 25 424 093
2024-04-02 $0.0734 $0.0740 $0.0710 $0.0740 21 974 107
2024-04-01 $0.0836 $0.0900 $0.0710 $0.0770 71 627 053
2024-03-28 $0.0725 $0.0899 $0.0713 $0.0899 58 419 701
2024-03-27 $0.0710 $0.0739 $0.0688 $0.0729 29 143 623
2024-03-26 $0.0728 $0.0730 $0.0653 $0.0690 41 435 870
2024-03-25 $0.0756 $0.0825 $0.0721 $0.0722 32 468 260
2024-03-22 $0.0800 $0.0802 $0.0700 $0.0719 50 821 768
2024-03-21 $0.0841 $0.0898 $0.0770 $0.0790 88 456 880
2024-03-20 $0.0990 $0.0999 $0.0731 $0.0799 189 266 361
2024-03-19 $0.0700 $0.0731 $0.0656 $0.0689 20 316 529
2024-03-18 $0.0732 $0.0735 $0.0662 $0.0694 19 960 978
2024-03-15 $0.0705 $0.0808 $0.0700 $0.0700 28 697 870
Click to get the best stock tips daily for free!

About Jaguar Health, Inc.

Jaguar Health. Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer fo... JAGX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT